Transdermal & Intradermal Drug Delivery Systems

Transdermal Drug Delivery system is an integral part of novel drug delivery system. Drugs having long pharmacokinetic half-lives are considered to be Unsuitable for transdermal application. By the increased number of marketing authorization applications together with recent scientific developments for transdermal patches, the need for clear guidance on specific requirements for this dosage form increased.

The emergence of technological innovations in transdermal patches is expected to provide the market with lucrative growth opportunities over the coming years. Transdermal Drug Delivery system was valued at $32,516 million in 2016, and is estimated to reach $61,689 million by 2023, growing at a CAGR of 9.5%.

 

  • Novel Delivery Systems for Transdermal drug delivery
  • Applications of Transdermal Delivery
  • Advances in Intradermal Drug Delivery
  • Computational Modeling of Transdermal and Intradermal Delivery

Related Conference of Transdermal & Intradermal Drug Delivery Systems

Transdermal & Intradermal Drug Delivery Systems Conference Speakers